Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
Clinical trial NCT04477876 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04477876
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-01
- Primary completion
- 2027-12-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.